Wrong, Cramer! Livongo Rival Omada Health’s Physera Buy Aims At $200B Opportunity - News Summed Up

Wrong, Cramer! Livongo Rival Omada Health’s Physera Buy Aims At $200B Opportunity


Digital health care providers have stepped into the breach. One privately-held rival, San Francisco-based Omada Health, recently chose to expand from digital diabetes and mental health services to a surprising new health care vertical market — digital physical therapy. One such rival is Omada Health which has raised over $250 million, “making it one of the most highly valued digital health companies. As Duffy told me, “This is a fascinating moment for health care it is moving to the cloud. Covid-19 has created the need for an option B for employee health care delivery based on outcomes and customer experience.


Source: Forbes July 18, 2020 13:11 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */